Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91


Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice.

Huang YH, Zugates GT, Peng W, Holtz D, Dunton C, Green JJ, Hossain N, Chernick MR, Padera RF Jr, Langer R, Anderson DG, Sawicki JA.

Cancer Res. 2009 Aug 1;69(15):6184-91. doi: 10.1158/0008-5472.CAN-09-0061.


Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells.

Cocco E, Deng Y, Shapiro EM, Bortolomai I, Lopez S, Lin K, Bellone S, Cui J, Menderes G, Black JD, Schwab CL, Bonazzoli E, Yang F, Predolini F, Zammataro L, Altwerger G, de Haydu C, Clark M, Alvarenga J, Ratner E, Azodi M, Silasi DA, Schwartz PE, Litkouhi B, Saltzman WM, Santin AD.

Mol Cancer Ther. 2017 Feb;16(2):323-333. doi: 10.1158/1535-7163.MCT-16-0501. Epub 2016 Dec 12.


Nanoparticle delivery of suicide DNA for epithelial ovarian cancer therapy.

Sawicki JA, Anderson DG, Langer R.

Adv Exp Med Biol. 2008;622:209-19. doi: 10.1007/978-0-387-68969-2_17. Review.


Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors.

Peng W, Anderson DG, Bao Y, Padera RF Jr, Langer R, Sawicki JA.

Prostate. 2007 Jun 1;67(8):855-62.


Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.

Yang F, Gou M, Deng H, Yi T, Zhong Q, Wei Y, Zhao X.

Oncol Rep. 2012 Aug;28(2):668-76. doi: 10.3892/or.2012.1853. Epub 2012 Jun 6.


Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.

Berry NB, Cho YM, Harrington MA, Williams SD, Foley J, Nephew KP.

Gynecol Oncol. 2004 Mar;92(3):896-904.


Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy.

Breidenbach M, Rein DT, Everts M, Glasgow JN, Wang M, Passineau MJ, Alvarez RD, Korokhov N, Curiel DT.

Gene Ther. 2005 Jan;12(2):187-93.


Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.

Luo L, Du T, Zhang J, Zhao W, Cheng H, Yang Y, Wu Y, Wang C, Men K, Gou M.

Int J Nanomedicine. 2016 Feb 2;11:501-12. doi: 10.2147/IJN.S93496. eCollection 2016.


Development of poly(β-amino ester)-based biodegradable nanoparticles for nonviral delivery of minicircle DNA.

Keeney M, Ong SG, Padilla A, Yao Z, Goodman S, Wu JC, Yang F.

ACS Nano. 2013 Aug 27;7(8):7241-50. doi: 10.1021/nn402657d. Epub 2013 Jul 16.


Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells.

Showalter SL, Huang YH, Witkiewicz A, Costantino CL, Yeo CJ, Green JJ, Langer R, Anderson DG, Sawicki JA, Brody JR.

Cancer Biol Ther. 2008 Oct;7(10):1584-90. Epub 2008 Oct 3.


A polymer library approach to suicide gene therapy for cancer.

Anderson DG, Peng W, Akinc A, Hossain N, Kohn A, Padera R, Langer R, Sawicki JA.

Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):16028-33. Epub 2004 Nov 1.


Efficient inhibition of ovarian cancer by truncation mutant of FILIP1L gene delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.

Xie C, Gou ML, Yi T, Deng H, Li ZY, Liu P, Qi XR, He X, Wei Y, Zhao X.

Hum Gene Ther. 2011 Nov;22(11):1413-22. doi: 10.1089/hum.2011.047. Epub 2011 Jun 8.


The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.

Peng XY, Won JH, Rutherford T, Fujii T, Zelterman D, Pizzorno G, Sapi E, Leavitt J, Kacinski B, Crystal R, Schwartz P, Deisseroth A.

Cancer Res. 2001 Jun 1;61(11):4405-13.


Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft.

Huang X, Lin T, Gu J, Zhang L, Roth JA, Stephens LC, Yu Y, Liu J, Fang B.

Gene Ther. 2002 Oct;9(20):1379-86.


The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.

Liu P, Gou M, Yi T, Qi X, Xie C, Zhou S, Deng H, Wei Y, Zhao X.

Int J Oncol. 2012 Oct;41(4):1504-12. doi: 10.3892/ijo.2012.1558. Epub 2012 Jul 18.


Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells.

Peng W, Chen J, Huang YH, Sawicki JA.

Gene Ther. 2005 Nov;12(21):1573-80.


A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer.

Rein DT, Breidenbach M, Kirby TO, Han T, Siegal GP, Bauerschmitz GJ, Wang M, Nettelbeck DM, Tsuruta Y, Yamamoto M, Dall P, Hemminki A, Curiel DT.

Clin Cancer Res. 2005 Feb 1;11(3):1327-35.


A nanoparticle formulation that selectively transfects metastatic tumors in mice.

Yang J, Hendricks W, Liu G, McCaffery JM, Kinzler KW, Huso DL, Vogelstein B, Zhou S.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14717-22. doi: 10.1073/pnas.1313330110. Epub 2013 Aug 19.


HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector.

Wang Y, Canine BF, Hatefi A.

Nanomedicine. 2011 Apr;7(2):193-200. doi: 10.1016/j.nano.2010.08.003. Epub 2010 Oct 1.

Supplemental Content

Support Center